D-1258-2020 Class III Terminated
FDA drug recall D-1258-2020 was initiated by Akorn Inc on Mar 25, 2020 and is designated Class III. Reason for recall: Failed impurities/degradation specification: Out-of-Specification result for total impurity at 4.1% (Limit: NMT 3.0%) during retained sample testing. The recall status is terminated (terminated Jul 28, 2022). Affected quantity: 15,170 ampules.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 8, 2020
- Initiation Date
- Mar 25, 2020
- Termination Date
- Jul 28, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 15,170 ampules
Product description
Fentanyl Citrate Injection, USP, 100 mcg/2 mL (50 mcg/mL), 10 Ampules per carton, (2 mL each), Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-030-02
Reason for recall
Failed impurities/degradation specification: Out-of-Specification result for total impurity at 4.1% (Limit: NMT 3.0%) during retained sample testing.
Distribution pattern
Distributed Nationwide in the USA
Code information
Lot 081887A, EXP 08/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1258-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026